Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service

Research output: Contribution to journalReview articlepeer-review

60 Citations (Scopus)

Abstract

The aim of this case series is to describe and evaluate our experience of continuous positive airway pressure (CPAP) to treat type 1 respiratory failure in patients with COVID-19. CPAP was delivered in negative pressure rooms in the newly repurposed infectious disease unit. We report a cohort of 24 patients with type 1 respiratory failure and COVID-19 admitted to the Royal Liverpool Hospital between 1 April and 30 April 2020. Overall, our results were positive; we were able to safely administer CPAP outside the walls of a critical care or high dependency unit environment and over half of patients (58%) avoided mechanical ventilation and a total of 19 out of 24 (79%) have survived and been discharged from our care.

Original languageEnglish
Article numbere000639
Pages (from-to)e000639
JournalBMJ Open Respiratory Research
Volume7
Issue number1
DOIs
Publication statusPublished - 5 Jul 2020

Keywords

  • non invasive ventilation
  • respiratory Infection

Fingerprint

Dive into the research topics of 'Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service'. Together they form a unique fingerprint.

Cite this